Acute pancreatitis, a rare but severe side effect of DPP4 inhibitors, was associated with increased activity of GLP-1, which can cause ductal hyperplasia in the pancreas with outflow obstruction leading to intrapancreatic activation of pancreatic enzymes [18,56]. The gene discussed is DPP4; the disease is acute pancreatitis.